Investor Relations | Financial Information

Capex, Depeciation, R&D

Unit:Yen millions / Fiscal Year 2015/3 2016/3 2017/3 2018/3 2019/3
Investment in facilities
Share of cash flow (%)
102,525
79.1
160,674
108.5
167,631
72.1
178,612
114.8
173,592
91.9
Depreciation expenses
Share of net sales (%)
80,249
7.4
83,224
7.2
87,491
7.4
92,171
7.2
106,631
7.7
Cash flow
(Net income + Depreciation expenses)
129,689 148,052 232,590 155,634 188,836
Research and development expenses
 Share of net sales (%)
70,644
6.5
84,920
7.4
91,254
7.7
102,641
8.1
115,155
8.3
  • Notes:
    The prior year's results are reclassified due to adoption of Accounting Standards Update("ASU") 2017-07 "Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postrequirement Benefit Cost". As a result of this reclassification, research and development was changed.
Interactive Analysis Tool

Recommendations

PAGE TOP